JP2022060192A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2022060192A5 JP2022060192A5 JP2021194722A JP2021194722A JP2022060192A5 JP 2022060192 A5 JP2022060192 A5 JP 2022060192A5 JP 2021194722 A JP2021194722 A JP 2021194722A JP 2021194722 A JP2021194722 A JP 2021194722A JP 2022060192 A5 JP2022060192 A5 JP 2022060192A5
- Authority
- JP
- Japan
- Prior art keywords
- fluorobenzofuran
- methylaminomethyl
- phenyl
- water
- carboxamide hydrochloride
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims 13
- GPFWTAVHQKERKY-UHFFFAOYSA-N mefuparib hydrochloride Chemical compound Cl.CNCc1ccc(cc1)-c1cc2cc(F)cc(C(N)=O)c2o1 GPFWTAVHQKERKY-UHFFFAOYSA-N 0.000 claims 12
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims 6
- 239000013078 crystal Substances 0.000 claims 5
- 239000003960 organic solvent Substances 0.000 claims 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims 5
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims 3
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims 3
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims 3
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 3
- 238000000634 powder X-ray diffraction Methods 0.000 claims 3
- 238000001228 spectrum Methods 0.000 claims 3
- 238000003756 stirring Methods 0.000 claims 3
- KBPLFHHGFOOTCA-UHFFFAOYSA-N 1-Octanol Chemical compound CCCCCCCCO KBPLFHHGFOOTCA-UHFFFAOYSA-N 0.000 claims 2
- BBMCTIGTTCKYKF-UHFFFAOYSA-N 1-heptanol Chemical compound CCCCCCCO BBMCTIGTTCKYKF-UHFFFAOYSA-N 0.000 claims 2
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 claims 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 claims 2
- AMQJEAYHLZJPGS-UHFFFAOYSA-N N-Pentanol Chemical compound CCCCCO AMQJEAYHLZJPGS-UHFFFAOYSA-N 0.000 claims 2
- 229920000776 Poly(Adenosine diphosphate-ribose) polymerase Polymers 0.000 claims 2
- DKGAVHZHDRPRBM-UHFFFAOYSA-N Tert-Butanol Chemical compound CC(C)(C)O DKGAVHZHDRPRBM-UHFFFAOYSA-N 0.000 claims 2
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 claims 2
- MWKFXSUHUHTGQN-UHFFFAOYSA-N decan-1-ol Chemical compound CCCCCCCCCCO MWKFXSUHUHTGQN-UHFFFAOYSA-N 0.000 claims 2
- 238000001035 drying Methods 0.000 claims 2
- ZSIAUFGUXNUGDI-UHFFFAOYSA-N hexan-1-ol Chemical compound CCCCCCO ZSIAUFGUXNUGDI-UHFFFAOYSA-N 0.000 claims 2
- 238000004519 manufacturing process Methods 0.000 claims 2
- 238000000034 method Methods 0.000 claims 2
- 239000007787 solid Substances 0.000 claims 2
- ZQXSFZAMFNRZOQ-UHFFFAOYSA-N 2-methylpropan-2-ol;hydrate Chemical compound O.CC(C)(C)O ZQXSFZAMFNRZOQ-UHFFFAOYSA-N 0.000 claims 1
- BZLVMXJERCGZMT-UHFFFAOYSA-N Methyl tert-butyl ether Chemical compound COC(C)(C)C BZLVMXJERCGZMT-UHFFFAOYSA-N 0.000 claims 1
- 230000002378 acidificating effect Effects 0.000 claims 1
- 230000001476 alcoholic effect Effects 0.000 claims 1
- KTUQUZJOVNIKNZ-UHFFFAOYSA-N butan-1-ol;hydrate Chemical compound O.CCCCO KTUQUZJOVNIKNZ-UHFFFAOYSA-N 0.000 claims 1
- FZIRSARZZCFABR-UHFFFAOYSA-N decan-1-ol;hydrate Chemical compound O.CCCCCCCCCCO FZIRSARZZCFABR-UHFFFAOYSA-N 0.000 claims 1
- 201000010099 disease Diseases 0.000 claims 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- IDGUHHHQCWSQLU-UHFFFAOYSA-N ethanol;hydrate Chemical compound O.CCO IDGUHHHQCWSQLU-UHFFFAOYSA-N 0.000 claims 1
- JEGUKCSWCFPDGT-UHFFFAOYSA-N h2o hydrate Chemical compound O.O JEGUKCSWCFPDGT-UHFFFAOYSA-N 0.000 claims 1
- MRFIFYAFCKVKST-UHFFFAOYSA-N heptan-1-ol;hydrate Chemical compound O.CCCCCCCO MRFIFYAFCKVKST-UHFFFAOYSA-N 0.000 claims 1
- QLPMOCCEEYMNEC-UHFFFAOYSA-N hexan-1-ol;hydrate Chemical compound O.CCCCCCO QLPMOCCEEYMNEC-UHFFFAOYSA-N 0.000 claims 1
- JMMWKPVZQRWMSS-UHFFFAOYSA-N isopropanol acetate Natural products CC(C)OC(C)=O JMMWKPVZQRWMSS-UHFFFAOYSA-N 0.000 claims 1
- 229940011051 isopropyl acetate Drugs 0.000 claims 1
- GWYFCOCPABKNJV-UHFFFAOYSA-N isovaleric acid Chemical compound CC(C)CC(O)=O GWYFCOCPABKNJV-UHFFFAOYSA-N 0.000 claims 1
- ROBJKLPZIPNAMV-UHFFFAOYSA-N mefuparib Chemical compound C1=CC(CNC)=CC=C1C1=CC2=CC(F)=CC(C(N)=O)=C2O1 ROBJKLPZIPNAMV-UHFFFAOYSA-N 0.000 claims 1
- GBMDVOWEEQVZKZ-UHFFFAOYSA-N methanol;hydrate Chemical compound O.OC GBMDVOWEEQVZKZ-UHFFFAOYSA-N 0.000 claims 1
- 125000006533 methyl amino methyl group Chemical group [H]N(C([H])([H])[H])C([H])([H])* 0.000 claims 1
- 239000000203 mixture Substances 0.000 claims 1
- HGASFNYMVGEKTF-UHFFFAOYSA-N octan-1-ol;hydrate Chemical compound O.CCCCCCCCO HGASFNYMVGEKTF-UHFFFAOYSA-N 0.000 claims 1
- LBFCRPJWCIHPSX-UHFFFAOYSA-N pentan-1-ol;hydrate Chemical compound O.CCCCCO LBFCRPJWCIHPSX-UHFFFAOYSA-N 0.000 claims 1
- 239000000546 pharmaceutical excipient Substances 0.000 claims 1
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 claims 1
- KIDBBTHHMJOMAU-UHFFFAOYSA-N propan-1-ol;hydrate Chemical compound O.CCCO KIDBBTHHMJOMAU-UHFFFAOYSA-N 0.000 claims 1
- 150000003839 salts Chemical class 0.000 claims 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 claims 1
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201710449281.2A CN109134409B (zh) | 2017-06-14 | 2017-06-14 | 盐酸美呋哌瑞多晶型物及其制备方法与应用 |
| CN201710449281.2 | 2017-06-14 | ||
| PCT/CN2018/089222 WO2018228205A1 (zh) | 2017-06-14 | 2018-05-31 | 盐酸美呋哌瑞多晶型物及其制备方法与应用 |
| JP2020519169A JP7432503B2 (ja) | 2017-06-14 | 2018-05-31 | 塩酸メフパリブの多形体およびその製造方法と使用 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020519169A Division JP7432503B2 (ja) | 2017-06-14 | 2018-05-31 | 塩酸メフパリブの多形体およびその製造方法と使用 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022060192A JP2022060192A (ja) | 2022-04-14 |
| JP2022060192A5 true JP2022060192A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | 2022-08-26 |
Family
ID=64660851
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020519169A Active JP7432503B2 (ja) | 2017-06-14 | 2018-05-31 | 塩酸メフパリブの多形体およびその製造方法と使用 |
| JP2021194722A Pending JP2022060192A (ja) | 2017-06-14 | 2021-11-30 | 塩酸メフパリブの多形体およびその製造方法と使用 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020519169A Active JP7432503B2 (ja) | 2017-06-14 | 2018-05-31 | 塩酸メフパリブの多形体およびその製造方法と使用 |
Country Status (11)
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN109134409B (zh) * | 2017-06-14 | 2023-09-29 | 中国科学院上海药物研究所 | 盐酸美呋哌瑞多晶型物及其制备方法与应用 |
| CN111320596B (zh) * | 2018-12-14 | 2024-07-05 | 甫康（上海）健康科技有限责任公司 | 盐酸美呋哌瑞多晶型物及其制备方法 |
| US20240016775A1 (en) * | 2020-02-24 | 2024-01-18 | Fukang (Shanghai) Health Technology Co., Ltd | Anti-coronavirus application of poly adp ribose polymerase inhibitor |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103242273B (zh) * | 2012-02-09 | 2015-06-03 | 中国科学院上海药物研究所 | 2-芳基苯并呋喃-7-甲酰胺类化合物、其制备方法及用途 |
| CN102627620B (zh) * | 2012-04-10 | 2015-12-16 | 江苏先声药物研究有限公司 | 一类苯并呋喃衍生物及其医药应用 |
| CN104003979B (zh) * | 2013-02-21 | 2016-08-17 | 上海汇伦生命科技有限公司 | 苯并咪唑-2-哌嗪类化合物、其药物组合物及其制备方法和用途 |
| WO2015032328A1 (zh) * | 2013-09-03 | 2015-03-12 | 四川海思科制药有限公司 | 茚满衍生物及其制备方法和在医药上的应用 |
| CN104003940B (zh) * | 2014-06-16 | 2017-02-15 | 华东理工大学 | 2,4‑二氟‑5‑(酞嗪酮‑1‑甲基)‑苯甲酰哌嗪类化合物及其用途 |
| CN109134409B (zh) * | 2017-06-14 | 2023-09-29 | 中国科学院上海药物研究所 | 盐酸美呋哌瑞多晶型物及其制备方法与应用 |
| CN111320596B (zh) * | 2018-12-14 | 2024-07-05 | 甫康（上海）健康科技有限责任公司 | 盐酸美呋哌瑞多晶型物及其制备方法 |
-
2017
- 2017-06-14 CN CN201710449281.2A patent/CN109134409B/zh active Active
-
2018
- 2018-05-31 WO PCT/CN2018/089222 patent/WO2018228205A1/zh not_active Ceased
- 2018-05-31 EP EP18818471.7A patent/EP3643708B1/en active Active
- 2018-05-31 CA CA3067336A patent/CA3067336C/en active Active
- 2018-05-31 JP JP2020519169A patent/JP7432503B2/ja active Active
- 2018-05-31 SG SG11201912281PA patent/SG11201912281PA/en unknown
- 2018-05-31 KR KR1020207000951A patent/KR102458566B1/ko active Active
- 2018-05-31 AU AU2018286057A patent/AU2018286057B2/en active Active
- 2018-05-31 US US16/623,297 patent/US11174237B2/en active Active
- 2018-06-14 TW TW107120585A patent/TWI675027B/zh active
-
2020
- 2020-01-13 ZA ZA2020/00224A patent/ZA202000224B/en unknown
-
2021
- 2021-11-30 JP JP2021194722A patent/JP2022060192A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022060192A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | ||
| JP2010519247A (ja) | 結晶性ミノサイクリン塩基及びその製造方法 | |
| JP2014524920A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | ||
| JP2018502909A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | ||
| KR20100113542A (ko) | 보센탄, 그의 결정다형 형태 및 그의 염의 합성 방법 | |
| WO2016055918A1 (en) | Novel stable polymorphs of isavuconazole or its salt thereof | |
| CN107698574B (zh) | 一种高纯度阿瑞匹坦的精制制备工艺 | |
| CA2890961A1 (en) | Novel polymorphs of azilsartan medoxomil | |
| CA2819118A1 (en) | A process for the preparation of pazopanib using novel intermediate | |
| JP7432503B2 (ja) | 塩酸メフパリブの多形体およびその製造方法と使用 | |
| JP2006513185A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | ||
| WO2018185711A1 (en) | Solvates of eluxadoline | |
| KR101032600B1 (ko) | 고순도 레바미피드의 제조방법 | |
| EP3081554B1 (en) | Method for preparing silodosin and intermediate thereof | |
| AU2014339222B2 (en) | A crystalline anhydrous form of Cabazitaxel, process for the preparation and pharmaceutical compositions thereof | |
| CN100352818C (zh) | 一种改进的制备阿折地平的方法 | |
| EP2155698A1 (en) | Novel thermodynamically stable polymorphic form-l of letrozole | |
| CN109180564B (zh) | 一种哌啶及其衍生物的制备方法 | |
| CN108101892B (zh) | 一种白杨素非天然氨基酸衍生物及其制备方法和应用 | |
| KR20180105450A (ko) | 피마살탄 콜린염 및 이의 수화물의 제조방법 | |
| JP4790901B2 (ja) | ４−アミノ−５−シアノイミダゾール誘導体及びその中間体の製造方法 | |
| CN105111136B (zh) | 一种制备3‑甲基‑1‑苯乙基哌啶‑4‑酮或1‑苯乙基哌啶‑4‑酮的方法 | |
| CN102633775B (zh) | 一种甲磺酸伊马替尼α晶型的制备方法 | |
| JP7033662B2 (ja) | 大規模なトリミドンの調製方法 | |
| CN109081812B (zh) | 4-(1-羟基-1-甲基乙基)-2-丙基咪唑-5-羧酸乙酯一水合物 |